Abstract
Background:
Although subtle differences in cortico-striato-thalamo-cortical (CTSC) circuit structure and function are critical to the current understanding of the neurocircuitry in obsessive-compulsive disorder (OCD), emerging evidence suggests that the cerebellum may also be involved. However, much of this evidence comes from studies with small samples and notable methodological heterogeneity.
Methods:
We conducted a mega-analysis of individual participant data on cerebellar sub-regional volumes, comparing individuals with OCD and healthy controls (HC) from the ENIGMA-OCD Working Group. 3D T1-weighted volumetric structural brain magnetic resonance imaging (MRI) scans from 1,954 individuals with OCD and 2,091 HC across 22 sites (40 datasets) were processed using the ACAPULCO (Automatic Cerebellum Anatomical Parcellation using U-Net Locally Constrained Optimization) pipeline to extract cerebellar parcellations. We harmonized the volume measures across sites using the ComBat algorithm. Multiple linear regression models were fitted to estimate group differences separately within the pediatric (<12 years), adolescent (12–18 years), and adult (from 18 years) samples, adjusting for age, gender, and intracranial volume (ICV).
Results:
In adults with OCD (versus HC), we found significantly smaller volumes of the corpus medullare (d=−0.093, pfdr=0.036), left VIIb (d=−0.085, pfdr=0.039) and right VIIb (d= −0.091, pfdr= 0.036). None of the comparisons between children or adolescents with OCD versus HC remained statistically significant after FDR correction. In all three age groups, cerebellar (subregional) volumes were significantly moderated by medication status.
Conclusions:
We report novel findings implicating specific cerebellar sub-regions across developmental stages of OCD, and the key impact of medication status. Further research on the functional significance of these findings may offer new translational leads.
Keywords: obsessive-compulsive disorder, OCD, cerebellum, structural MRI, mega-analysis
Introduction
Obsessive-compulsive disorder (OCD) is a chronic and often debilitating mental disorder with a worldwide prevalence between 1–3% (1). The neurobiological basis of OCD has generally been linked to subtle structural and functional differences (vs healthy controls) in the cortico-striato-thalamo-cortical (CSTC), fronto-limbic and fronto-parietal circuits. An extensive body of research using structural and functional magnetic resonance imaging (MRI), including findings from the ENIGMA-OCD Working Group (2), has generally supported this hypothesis. These findings have had a translational impact, as they inform our current approaches for neuromodulatory treatments. So far, the primary focus of neuromodulation in OCD has been limited to regions within the (pre)frontal cortex (for non-invasive stimulation) or the subcortical structures (for deep brain stimulation), all of which are closely linked to the CSTC circuits (3). However, recent evidence suggests that neurobiological alterations may be more diffuse and implicate regions outside of the fronto-striatal circuits, including the cerebellum (4–6).
The cerebellum is a complex structure. Though it occupies only about 10% of the overall brain volume, it houses approximately 80% of neurons in terms of number and is understood to have undergone considerable evolutionary expansion in humans (7). Previously, its functions were understood to be related to motor coordination and speech; it is now widely recognized that these functions extend far beyond and into several cognitive and emotional processes (Beuriat et al., 2022; Schmahmann, 2019, King M et al 2019). Many functional MRI studies have demonstrated a rich network of connections from the cerebellum to various CSTC areas (10,11). The cognitive/affective domains in which the cerebellum has a role also include fear conditioning (12) and habit formation (13), both of which are highly relevant to the etiopathogenesis of OCD (14).
Several studies have consistently reported differences in fMRI-based connectivity within the cerebellum in OCD, compared to healthy controls (HC) (6,15–19). However, most of these studies have been limited by their small sample sizes (ranging between 20–45 OCD participants), and heterogeneous methodology. There have been fewer structural studies of the cerebellum in OCD (20–22). These studies, which have used voxel-based morphometry (VBM) analyses, have been inconsistent, with reports of larger cerebellar anterior gray matter volume (Pujol et al., 2004) as well as smaller posterior lobe region volume (lobule VI and left crus VI). Recent meta-analyses of these VBM studies have also found increased grey matter volume in the cerebellum in adults (23,24). An important distinction between the studies’ samples was that few (e.g, Narayanaswamy et al. 2016) included a drug-naïve sample, while most other studies included medicated samples. Evidence from the ENIGMA-OCD consortium has clearly demonstrated that medication status can significantly impact brain macro- and microstructure in OCD, both in cortical and subcortical regions (Bruin et al., 2020; Ivanov et al., 2022; Piras et al., 2021).
Another limitation of the existing literature is that most studies have focused only on adult samples. Previous ENIGMA-OCD studies have shown that morphometric differences vary across the lifespan. Cerebellar growth trajectories within its sub-regions are understood to be differentially affected in neurodevelopmental disorders (27). There is a need to examine this in large sample sizes. We thus conducted a mega-analysis using data from the worldwide ENIGMA-OCD consortium, to investigate sub-regional cerebellar volumes across the lifespan, taking into account medication status. We hypothesized that individuals with OCD (as compared to HC) have smaller cerebellar sub-regional volumes, particularly in the posterior lobe. We also hypothesized that cerebellar sub-regional volume differences would be influenced by developmental stage (adult vs adolescent vs pediatric), age of illness onset and medication status.
Methods
Sample description
The ENIGMA-OCD working group is a worldwide collaboration of research institutes that jointly contribute individual-participant data from OCD patients and HC for mega-analysis of brain structure and function (2). These samples overlap with several of the previous analyses performed by ENIGMA-OCD. We divided the participants into three age groups: children (under 12 years), adolescents (12–17 years), and adults (from 18 years). The final dataset included 4,045 participants, of whom 1,954 were OCD patients (88 children, 265 adolescents, 1,601 adults) and 2,091 healthy controls (103 children, 240 adolescents, 1,748 adults). The institutional review boards of each participating site permitted the analysis of measures extracted from coded, de-identified individual participant data. Supplementary Table 1 describes the samples from each site, their inclusion criteria and the MRI structural acquisition protocols.
Image Acquisition and Processing
3D volumetric T1-weighted structural MRI images of each participant were processed using the Automatic Cerebellum Anatomical Parcellation with U-Net and Locally Constrained Optimization method (ACAPULCO) (28). In this automated pipeline, image intensity inhomogeneities were first corrected using the N4 method, followed by smoothing with a 3D Gaussian filter (SD = 3 mm), and re-aligning to the MNI standard brain space. A two-step deep-learning-based convolutional neural network (CNN) approach was used to create a 3D bounding box around the cerebellum, and then subdivide it into distinct anatomical areas. Volumetric measurements (in mm3) for the entire cerebellum and its 28 sub-regions were then derived. These regions included the hemispheric anterior lobes (lobules I-III, IV, and V), posterior lobes (lobules VI, VIIb, VIIIa, VIIIb, IX, and crus I-II), the flocculonodular lobe (lobule X), the vermal lobules VI, VII, VIII, IX, and X, and the corpus medullare (Figure 1).
Fig 1. Representative image of the cerebellar sub-regional parcellation of the MNI-152 1mm image using ACAPULCO.

Following segmentation, a quality control procedure was employed (29), consisting of (1) flagging of statistical outliers ± 2.689 SD from the site mean, and (2) visual inspection of cerebellar parcels. The study investigators at each site visually inspected each subject’s segmentation, and they excluded images in which the parcellation failed prior to data sharing. In addition, the pipeline provided visual graphs with boxplots to detect and further inspect statistical outliers, to check if they resulted from parcellation failures. The manual for the quality check protocols employed can be found online (https://enigma.ini.usc.edu/protocols/imaging-protocols/). In addition, the total intracranial volume (ICV) was estimated using FreeSurfer’s autorecon-1 algorithm (http://surfer.nmr.mgh.harvard.edu/) as part of the containerised package.
Statistical Analysis
Statistical analyses were conducted in accordance with statistical protocols of the ENIGMA Consortium (https://enigma.ini.usc.edu/protocols/statistical-protocols/). We chose to perform mega-analyses, by pooling the extracted volume measures for each participant across all sites. Cross-site harmonization, to adjust for possible batch effects, was performed using the ComBat function (30). Supplementary Figure 1 illustrates the impact of using the ComBat function on two representative volumes (total cerebellar volume and corpus medullare). Multiple linear regression models were run on the harmonized data.
We conducted separate analyses for the pediatric, adolescent and adult samples. The bilateral mean volumes of the 28 subregions served as the main outcome measures. The diagnosis was used as a binary predictor in all multiple regression analyses. All models were adjusted for age, gender, and total ICV. Medication effects were investigated by conducting stratified analyses comparing medicated and unmedicated OCD patients separately, versus the HC group. We additionally investigated the interaction of age and gender with diagnosis, in the total sample without stratifying between age groups. The association between OCD severity (total score in the YBOCS/C-YBOCS scales) was also examined in the OCD sample. The main analyses were corrected for multiple comparisons by applying a Benjamini–Hochberg false discovery rate correction (q = 0.05) across the 28 subregions tested. We also report uncorrected results throughout the manuscript. We computed Cohen’s d effect sizes using the t-statistic of the main predictor variable in the regression models.
Results
Demographic and clinical characteristics in the pooled sample:
A summary of the key demographic and clinical characteristics of the sample between the three age groups pooled across the sites is shown in Table 1. The gender ratio was skewed towards males in the pediatric sample, and slightly so within the adolescent sample. Roughly half of the adult and adolescent OCD samples were previously medicated; the proportion of medicated patients was much smaller in the pediatric sample.
Table 1.
Demographic and clinical characteristics of the sample pooled across sites
| Sample | Adult OCD | Adult HC | Adolescent OCD | Adolescent HC | Pediatric OCD | Pediatric HC |
|---|---|---|---|---|---|---|
| Sample size (n) | n=1,601 | n=1,748 | n=265 | n=240 | n=88 | n=103 |
| Age (mean (SD)) | 32.42 (9.72) | 30.55 (9.72) | 15.69 (1.58) | 15.53 (1.63) | 11.00 (1.75) | 10.72 (1.67) |
| Gender = Male (%) | 758 (47.4%) | 858 (49.1%) | 144 (54.3%) | 124 (51.7%) | 46 (59.7%) | 53 (52.0%) |
| Years of Education (mean (SD)) | 13.41 (3.66) | 15.35 (3.24) | 10.09 (2.00) | 9.68 (2.03) | 5.61 (1.57) | 5.15 (2.01) |
| (C)YBOCS (mean (SD)) | 24.35 (7.40) | -- | 20.37 (9.53) | -- | 19.17 (10.26) | -- |
| Pediatric onset of OCD | 757 (47.30%) | -- | -- | -- | -- | -- |
| Depression Comorbidity (Lifetime) (%) | 474 (29.6%) | -- | 96 (36.1%) | -- | 13 (15.1%) | -- |
| Anxiety Comorbidity (Lifetime) (%) | 370 (23.1%) | -- | 130 (49.1%) | -- | 32 (36.7%) | -- |
| Medicated (%) | 820 (51.2%) | -- | 120 (45.1%) | -- | 17 (17.9%) | -- |
(C)YBOCS - Yale Brown Obsessive-Compulsive Scale, Children/Adult version; OCD - Obsessive Compulsive Disorder, HC - Healthy Controls
Comparisons between OCD diagnosis vs Controls:
The between-group differences in the cerebellum lobular volumes, stratified across the age categories, are presented in Figure 2. The full results of each region in the adult, adolescent and pediatric samples are presented in Supplementary Tables 2, 3 and 4, respectively. In the adult sample, significantly smaller volumes were noted in the corpus medullare (d= −0.093, pfdr=0.036), left VIIb (d= −0.085, pfdr=0.039) and right VIIb (d= −0.091, pfdr= 0.036). In the adolescent sample, only the corpus medullare was found to be smaller but this did not survive FDR correction (d = −0.168, puncor = 0.044). In the pediatric sample, no findings survived FDR correction, but uncorrected results show larger volumes in OCD (vs HC) in four sub-regions: Left.I.III, Right.VI, Right.IV and the Vermis.VII (see Supplementary Table 4 for effect sizes)
Figure 2. Effect sizes of OCD vs Healthy Control comparisons of cerebellar lobule volumes across the three age categories (adult, adolescent and pediatric).

Age*Diagnosis and Sex*Diagnosis interaction effects in the total sample:
The results of the multivariate linear regression model examining the age x diagnosis interaction in the total sample are shown in Supplementary Table 5. None of the findings survived correction for multiple comparisons, but the uncorrected results show significant negative interaction effects in the left VI and left VIIa lobules, indicating greater age-related volume reductions in these regions within the OCD sample compared to controls. None of the Sex*Diagnosis interaction effects were found to be statistically significant even at the uncorrected p-value threshold, as shown in Supplementary Table 6.
Comparison between medicated vs unmedicated OCD:
Table 2 shows the results of the comparisons between the unmedicated and medicated OCD samples versus controls across the 3 age groups. The unmedicated adult OCD sample (versus HC) showed a larger volume of the left IX lobule (d = 0.177, pfdr = 0.041), while the medicated adult OCD sample (versus HC) showed a smaller volume of the corpus medullare (d = −0.151, pfdr = 0.023). Similar differences were noted in the pediatric and adolescent samples, with larger volumes in the unmedicated samples, but smaller volumes in the medicated samples (see Table 2 for details). Only a few of these results, however, survived FDR correction.
Table 2.
Comparisons between medicated and unmedicated OCD versus HC across the age categories
| Lobe | Cohens’d [95% CI] | P (uncorr) |
|---|---|---|
| Unmedicated OCD vs HC | ||
| Pediatric sample (NOCD =71, NHC=103) | ||
| Left.I.III | 0.39 [0.063 – 0.718] | 0.02 |
| Right.VI | 0.471 [0.149 – 0.793] | 0.004* |
| Adolescent sample (NOCD=145, NHC=240) | ||
| Vermis.VIII | 0.221 [0.045 – 0.397] | 0.014 |
| Adult sample (NOCD=781, NHC=1748) | ||
| Left.IX | 0.177 [0.067 – 0.286] | 0.002* |
| Left.X | 0.119 [0.01 – 0.228] | 0.033 |
| Right.IX | 0.133 [0.023 – 0.242] | 0.018 |
| Right.X | 0.126 [0.017 – 0.236] | 0.024 |
| Medicated OCD vs HC | ||
| Child sample (NOCD=17, NHC=103) | ||
| Corpus.Medullare | −0.751 [−1.335 – −0.166] | 0.012 |
| Left.VIIb | −1.189 [−1.77 – −0.609] | <0.001* |
| Left.X | −0.661 [−1.263 – −0.059] | 0.032 |
| Vermis.VII | −0.652 [−1.23 – −0.075] | 0.027 |
| Total Cerebellar Volume | −0.582 [−1.124 – −0.04] | 0.035 |
| Adolescent sample (NOCD =120, NHC=240) | ||
| Corpus.Medullare | −0.401 [−0.681 – −0.121] | 0.015 |
| Right.X | −0.415 [−0.709 – −0.122] | 0.006* |
| Adult sample (NOCD=820, NHC=1748) | ||
| Corpus.Medullare | −0.151 [−0.223 – −0.079] | <0.001* |
| Left.VIIb | −0.092 [−0.165 – −0.019] | 0.013 |
| Right.I.III | −0.084 [−0.159 – −0.009] | 0.028 |
| Right.VIIb | −0.097 [−0.171 – −0.024] | 0.01 |
| Vermis.X | −0.091 [−0.166 – −0.016] | 0.017 |
| Total Cerebellar Volume | −0.082 [−0.15 – −0.015] | 0.017 |
significant after FDR correction;
CI - Confidence Intervals; OCD - Obsessive-Compulsive Disorder; HC - Heathy Controls
We further examined the effect of medication status on the age x diagnosis interaction term, in the sub-regional volumes that were found to have differential results when looking at the age categories. Figure 3 shows the results of this analysis within the corpus medullare and the total cerebellar volume, where the developmental trajectories are significantly different in medicated versus unmedicated OCD samples.
Figure 3. Comparison of the age x diagnosis interaction in controls, medicated and unmedicated OCD.

Discussion
We conducted a mega-analysis of cerebellum sub-regional volumes in OCD, by leveraging the largest worldwide set of samples from the ENIGMA OCD Working Group. This enabled us to examine several aspects of the heterogeneity within OCD, and also investigate confounds such as medication status with adequate statistical power. Consistent with what we hypothesized, we found smaller cerebellar sub-regional volumes in OCD, but only in the adult sample, in bilateral VIIb lobule, and in the corpus medullare. We also found that medication status had a significant influence on cerebellar (subregional) volumes, as well as on the developmental trajectories. Findings that survived FDR correction were limited to the posterior lobules of the cerebellum, known to be involved in emotional and cognitive processes. These findings offer novel insights regarding the role of the cerebellum in OCD.
The central/midline structures of the cerebellum include the corpus medullare and the vermis. Corpus medullare is a central white matter structure, containing several prominent afferent & efferent tracts that relay between the cerebellum and the cerebrum (cortical & subcortical areas). It also contains several deep nuclei, particularly the dentate nucleus–the key output nucleus of the cerebellum. In our study, we showed that adolescent and adult (but not pediatric) individuals with OCD (versus HC) have smaller corpus medullare volumes. However, many of these differences appear to be driven by medication status, as we do not see any of these findings within the corpus medullare in the unmedicated samples. Prior studies of cerebellar morphology in OCD used VBM with the spatially unbiased atlas template of the cerebellum and brainstem (SUIT) toolbox (31), which does not provide a volumetric estimate of the corpus medullare. Hence this is a novel finding, hinting at the implications within either the white matter tracts, or the deep nuclei of the cerebellum.
We found that adult OCD status was associated with smaller volumes of bilateral VIIb. Lobule VIIb is functionally connected with the orbitofrontal, dorsolateral, and medial prefrontal cortex, supporting cognitive control (32). These regions are also highly relevant to OCD and have been the conventional targets for non-invasive neuromodulatory treatments in OCD (33). Additionally, alterations in lobule VIIb have been associated with developmental psychopathology in several studies (34,35).
We found that age-related decline in the total cerebellar volume was greater in medicated OCD patients, as compared to unmedicated OCD or controls. Whereas, the corpus medullare volume showed an opposite age effect in unmedicated OCD (positive correlation between age and volume) versus medicated OCD and HC (negative correlation). The volumetric alterations in OCD (vs HC) also involved different cerebellar lobules across different developmental stages. Key regions were again in the posterior lobules, and the corpus medullare (cerebellar white matter & deep nuclei). The region-specific volume differences across different age groups might indicate that the developmental trajectories of certain cerebellar lobules are altered in OCD. Medication status appears to have a significant influence on these developmental trajectories. Similar patterns have been seen in other cortical (frontal areas) and subcortical regions (thalamus, pallidum, hippocampus) (2,36), indicating that plasticity/neurodevelopmental alterations in OCD and/or medication use could affect all these brain regions synchronously throughout the lifespan. Large cohorts of unmedicated individuals would be required to understand these temporal dynamics, though such studies are largely unfeasible for ethical reasons.
Strengths of our study include the large sample size with representation across the globe, the use of a robust harmonized pipeline and quality inspection procedure, and the inclusion of pediatric, adolescent and adult samples. However, as the study was cross-sectional in nature, it is difficult to infer causality, especially with respect to the effects of medication. Details regarding the types of medication, dosages and duration of use were not available and could not be further analyzed. We used a relatively newer pipeline (ACAPULCO) for processing cerebellum volumes, while the majority of the previous studies have used the SUIT toolbox. Hence it may be difficult to compare our findings with those of previous studies, some of which have reported greater cerebellar grey matter volumes in OCD (37). We also could not estimate the test-retest reliability of the lobular volume estimates, which is recommended due to the wide within-subject variability, especially with ACAPULCO (38). Despite the large sample size, adults form the majority of participants and pediatric participants are relatively underrepresented. Few findings in the pediatric sample survived multiple comparisons, emphasizing the need for larger samples in the future.
Conclusion
In our sample of >4,000 subjects from the ENIGMA-OCD Working Group, we found that subregional volumes in the cerebellar white matter (corpus medullare) and the posterior regions (lobule VIIb bilaterally) are significantly smaller in adults with OCD. However, these alterations were mostly driven by the medicated individuals in our samples. Longitudinal samples of individuals who are drug-naive with post-treatment follow-up would help understand if these differences are indeed caused by medication use. Future studies could also focus on using multimodal approaches, assessing functional and structural connectivity between these cerebellar sub-regions and the conventional CSTC regions, to improve our understanding of the role of the cerebellum in OCD.
Supplementary Material
Supplement Description:
Funding Information:
The ENIGMA Obsessive-Compulsive Disorder Working Group gratefully acknowledges support from the NIH BD2K award U54 EB020403 (PI: P.M. Thompson) and Amsterdam Neuroscience (CIA-2019-03-A to O.A. van den Heuvel, Amsterdam Neuroscience Alliance Project to G.A. van Wingen). Supported by the Japan Society for the Promotion of Science (JSPS; KAKENHI Grants No. 18K15523 to Y. Abe, No. 19K03308 to Y. Hirano and A. Nakagawa, No. 16K04342 to A. Nakagawa); National Institute of Mental Health (NIMH; Grant no. 5R01MH116038 to A. Anticevic, No. R01MH085900 to J.D. Feusner,, No. R01MH085900 and No. R01MH081864 to J. O’Neill, No. 1R01MH081864 to J. Piacentini,); Swiss National Science Foundation (Grant No. 320030_130237) and the Hartmann Müller Foundation (Grant No. 1460) to S. Brem; Fundação Faculdade de Medicina (Grant No. 86.768 to D.L.C. Costa); the Japan Agency for Medical Research and Development (AMED Brain/MINDS Beyond program Grant No. JP21dm0307002 to Y. Hirano, No. JP21dm0307008 to Y. Sakai); Michael Smith Foundation for Health Research to F. Jaspers-Fayer; the Deutsche Forschungsgemeinschaft (DFG; to D. Rodriguez-Manrique, Grant No. DFG 815/6-1 to N. Kathmann, No. KO 3744/11–1 to K. Koch); The Basic Science Research Program through the National Research Foundation of Korea (NRF) (Grant no. 2019R1A2B5B03100844 to J.S. Kwon); the Marató TV3 Foundation (Grant No. 01/2010 and No. 091710 to L. Lazaro); the National Research Foundation of South Africa to C. Lochner; the Portuguese Foundation for Science and Technology (Fundação para a Ciência e a Tecnologia; FCT; Project No. UIDB/50026/2020 and No. UIDP/50026/2020 to P. Morgado and N. Sousa); the ICVS Scientific Microscopy Platform, member of the national infrastructure PPBI - Portuguese Platform of Bioimaging (Grant No. PPBI-POCI-01–0145-FEDER-022122); the Norte Portugal Regional Operational Programme (NORTE 2020; Grant No. NORTE-01–0145-FEDER-000039 to P. Morgado and N. Sousa), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF); the FLAD Science Award Mental Health 2021 to P. Morgado and N. Sousa; the Government of India grants from the Department of Science and Technology (Grants No. SR/S0/HS/0016/2011 to Y.C. Janardhan Reddy, and DST INSPIRE faculty grant -IFA12-LSBM-26 to J.C. Narayanaswamy) and from the Department of Biotechnology (Grants No. BT/PR13334/Med/30/259/2009 to Y.C. Janardhan Reddy, and No. -BT/06/IYBA/2012 to Dr. Janardhanan C. Narayanaswamy; the Italian Ministry of Health (Grant No. RC19–20-21 to Fabrizio Piras, No. RC18–19-20–21/A to G. Spalletta); the Wellcome Trust-DBT India Alliance (Grant No. 500236/Z/11/Z to G. Venkatasubramanian, Early Career Fellowship Grant No. IA/CPHE/18/1/503956 to. V. Shivakumar); the Carlos III Health Institute (Grant No. PI16/00889 and No. PI19/01171 to C. Soriano-Mas); the Departament de Salut, Generalitat de Catalunya (Grant No. PERIS SLT006/17/249 to C. Soriano-Mas); the Agència de Gestió d’Ajuts Universitaris i de Recerca (Grant No. 2017 SGR 1262 to C. Soriano-Mas); the International OCD Foundation to P.R. Szeszko; the Helse Vest Health Authority (Grant No. 911754 and No. 911880 to A.L. Thorsen); the Netherlands Organisation for Health Research and Development (ZonMw; VIDI Grant No. 91717306 to O.A. van den Heuvel, TOP Grant No. 91211021 to T. White); the South African Medical Research Council (SAMRC) to D.J. Stein; the Dutch Brain Foundation (Nederlandse Hersenstichting; Grant No. HA-2017–00227 to C. Vriend).
Consortium Authors:
We acknowledge that the following members of the ENIGMA-OCD Working Group have also contributed to this manuscript: Sara Poletti14, Elisa Melloni14, Anouk van der Straten21,45, Wieke van Leeuwen21,45, Akiko Nakagawa59, Naoko Kato17,18, Tsubasa Sasaki17,18, Euripedes C. Miguel11, Renata M. F. Silva11, Antonio C. Lopes11, Taekwan Kim65,66,67, Sanghoon Oh68, Junhee Lee68, Harin Oh19, Bjarne Hansen53,62, Astrid Morer7,41,42,43, Rosa Calvo7,41,42,43, Blanca Garcia-Delgar41, Marta Subirà6,7,8, Eva Real6,7,8, Cinto Segalàs6,7, Nuno Sousa20, Afonso Fernandes20, Pedro Moreira69, Beatriz Couto20, Takashi Nakamae4, Anri Watanabe4, Jin Narumoto4, Kei Yamada4, Jinsong Tang70, Simone Elia10, Federico Fiori Nastro71, Nicole Beyer9, Veit Roessner9
65. Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
66. Mental Health Neuroscience Department, Division of Psychiatry and Max Planck
67. UCL Centre for Computational Psychiatry and Ageing Research, Queen Square Institute of Neurology, UCL, London, UK
68. Department of Psychiatry, Uijeongbu Eulji Medical Center, Eulji University School of Medicine
69. School of Psychology, University of Minho, Braga, Portugal
70. Department of Psychiatry, Zhejiang University School of Medicine, Hangzhou, China
71. Department of Systems Medicine, Tor Vergata University of Rome, Italy - IRCCS Fondazione, Santa Lucia, Rome, Italy.
Footnotes
Competing Interests:
Jamie D. Feusner is affiliated with NOCD, LLC; Prof. Mataix-Cols receives personal fees from UpToDate, Inc and Elsevier, both outside the current work; Pedro Morgado has received in the past 3 years grants, CME-related honoraria, or consulting fees from Angelini, AstraZeneca, Bial Foundation, Biogen, DGS-Portugal, FCT, FLAD, Janssen-Cilag, Gulbenkian Foundation, Lundbeck, Springer Healthcare, Tecnimede and 2CA-Braga; Erika L. Nurmi served on the Scientific Advisory Board of Myriad Genetics and Medical Advisory Board of Tourette Association of America and Teva Pharmaceuticals;; Susanne Walitza received no funds of Industry Outside professional activities and interests are declared under the link of the University of Zurich www.uzh.ch/prof/ssl-dir/interessenbindungen/client/web/. Her work was supported in the last 5 years by the Swiss National Science Foundation (SNF), diverse EU FP7s, Gesundheitsförderung Schweiz, Bfarm Germany, ZInEP, Hartmann Müller Stiftung, Olga Mayenfisch, Gertrud Thalmann, Vontobel, Unicentia, Erika Schwarz Fonds. Paul M. Thompson received partial research support from Biogen, Inc., for research unrelated to this manuscript; Chris Vriend is listed as an inventor on a patent licensed to General Electronic (WO2018115148A1). Odile A. van den Heuvel received a consultation honorarium from Lundbeck. All other authors report no biomedical financial interests or potential conflicts of interest.
Publisher's Disclaimer: This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability. This version will undergo additional copyediting, typesetting and review before it is published in its final form. As such, this version is no longer the Accepted Manuscript, but it is not yet the definitive Version of Record; we are providing this early version to give early visibility of the article. Please note that Elsevier’s sharing policy for the Published Journal Article applies to this version, see: https://www.elsevier.com/about/policies-and-standards/sharing#4-published-journal-article. Please also note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Ruscio AM, Stein DJ, Chiu WT, Kessler RC (2010): The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 15: 53–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.van den Heuvel OA, Boedhoe PSW, Bertolin S, Bruin WB, Francks C, Ivanov I, et al. (2020): An overview of the first 5 years of the ENIGMA obsessive-compulsive disorder working group: The power of worldwide collaboration. Hum Brain Mapp. 10.1002/hbm.24972 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Shephard E, Stern ER, van den Heuvel OA, Costa DLC, Batistuzzo MC, Godoy PBG, et al. (2021): Toward a neurocircuit-based taxonomy to guide treatment of obsessive-compulsive disorder. Mol Psychiatry 26: 4583–4604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bruin WB, Abe Y, Alonso P, Anticevic A, Backhausen LL, Balachander S, et al. (2023): The functional connectome in obsessive-compulsive disorder: resting-state mega-analysis and machine learning classification for the ENIGMA-OCD consortium. Mol Psychiatry 28: 4307–4319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Perera MPN, Gotsis ES, Bailey NW, Fitzgibbon BM, Fitzgerald PB (2024): Exploring functional connectivity in large-scale brain networks in obsessive-compulsive disorder: a systematic review of EEG and fMRI studies. Cereb Cortex N Y NY 34: bhae327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Sha Z, Edmiston EK, Versace A, Fournier JC, Graur S, Greenberg T, et al. (2020): Functional Disruption of Cerebello-thalamo-cortical Networks in Obsessive-Compulsive Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging 5: 438–447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Sereno MI, Diedrichsen J, Tachrount M, Testa-Silva G, d’Arceuil H, De Zeeuw C (2020): The human cerebellum has almost 80% of the surface area of the neocortex. Proc Natl Acad Sci U S A 117: 19538–19543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Beuriat P-A, Cristofori I, Gordon B, Grafman J (2022): The shifting role of the cerebellum in executive, emotional and social processing across the lifespan. Behav Brain Funct BBF 18: 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Schmahmann JD (2019): The cerebellum and cognition. Neurosci Lett 688: 62–75. [DOI] [PubMed] [Google Scholar]
- 10.Bernard JA, Seidler RD, Hassevoort KM, Benson BL, Welsh RC, Wiggins JL, et al. (2012): Resting state cortico-cerebellar functional connectivity networks: a comparison of anatomical and self-organizing map approaches. Front Neuroanat 6: 31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bostan AC, Strick PL (2018): The basal ganglia and the cerebellum: nodes in an integrated network. Nat Rev Neurosci 19: 338–350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lange I, Kasanova Z, Goossens L, Leibold N, De Zeeuw CI, van Amelsvoort T, Schruers K (2015): The anatomy of fear learning in the cerebellum: A systematic meta-analysis. Neurosci Biobehav Rev 59: 83–91. [DOI] [PubMed] [Google Scholar]
- 13.Pierce JE, Péron JA (2022): Reward-Based Learning and Emotional Habit Formation in the Cerebellum. Adv Exp Med Biol 1378: 125–140. [DOI] [PubMed] [Google Scholar]
- 14.Stein DJ, Costa DLC, Lochner C, Miguel EC, Reddy YCJ, Shavitt RG, et al. (2019): Obsessive-compulsive disorder. Nat Rev Dis Primer 5: 52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Xing X, Jin L, Li Q, Yang Q, Han H, Xu C, et al. (2020): Modeling essential connections in obsessive-compulsive disorder patients using functional MRI. Brain Behav 10: e01499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Lv D, Ou Y, Chen Y, Yang R, Zhong Z, Jia C, et al. (2020): Increased cerebellar-default-mode network connectivity at rest in obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 270: 1015–1024. [DOI] [PubMed] [Google Scholar]
- 17.Murayama K, Tomiyama H, Tsuruta S, Ohono A, Kang M, Hasuzawa S, et al. (2021): Aberrant Resting-State Cerebellar-Cerebral Functional Connectivity in Unmedicated Patients With Obsessive-Compulsive Disorder. Front Psychiatry 12: 659616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Zhang H, Wang B, Li K, Wang X, Li X, Zhu J, et al. (2019): Altered Functional Connectivity Between the Cerebellum and the Cortico-Striato-Thalamo-Cortical Circuit in Obsessive-Compulsive Disorder. Front Psychiatry 10: 522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Xu T, Zhao Q, Wang P, Fan Q, Chen J, Zhang H, et al. (2019): Altered resting-state cerebellar-cerebral functional connectivity in obsessive-compulsive disorder. Psychol Med 49: 1156–1165. [DOI] [PubMed] [Google Scholar]
- 20.de Wit SJ, Alonso P, Schweren L, Mataix-Cols D, Lochner C, Menchón JM, et al. (2014): Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder. Am J Psychiatry 171: 340–349. [DOI] [PubMed] [Google Scholar]
- 21.Narayanaswamy JC, Jose D, Kalmady SV, Agarwal SM, Venkatasubramanian G, Janardhan Reddy YC (2016): Cerebellar volume deficits in medication-naïve obsessive compulsive disorder. Psychiatry Res Neuroimaging 254: 164–168. [DOI] [PubMed] [Google Scholar]
- 22.Pujol J, Soriano-Mas C, Alonso P, Cardoner N, Menchón JM, Deus J, Vallejo J (2004): Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry 61: 720–730. [DOI] [PubMed] [Google Scholar]
- 23.Del Casale A, Ferracuti S, Mancino S, Arena JF, Bilotta I, Alcibiade A, et al. (2024): A coordinate-based meta-analysis of grey matter volume differences between adults with obsessive-compulsive disorder (OCD) and healthy controls. Psychiatry Res Neuroimaging 345: 111908. [DOI] [PubMed] [Google Scholar]
- 24.Yang Z, Xiao S, Su T, Gong J, Qi Z, Chen G, et al. (2024): A multimodal meta-analysis of regional functional and structural brain abnormalities in obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 274: 165–180. [DOI] [PubMed] [Google Scholar]
- 25.Bruin WB, Taylor L, Thomas RM, Shock JP, Zhutovsky P, Abe Y, et al. (2020): Structural neuroimaging biomarkers for obsessive-compulsive disorder in the ENIGMA-OCD consortium: medication matters. Transl Psychiatry 10: 342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Ivanov I, Boedhoe PSW, Abe Y, Alonso P, Ameis SH, Arnold PD, et al. (2022): Associations of medication with subcortical morphology across the lifespan in OCD: Results from the international ENIGMA Consortium. J Affect Disord 318: 204–216. [DOI] [PubMed] [Google Scholar]
- 27.Sathyanesan A, Zhou J, Scafidi J, Heck DH, Sillitoe RV, Gallo V (2019): Emerging connections between cerebellar development, behavior, and complex brain disorders. Nat Rev Neurosci 20: 298–313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Han S, Carass A, He Y, Prince JL (2020): Automatic cerebellum anatomical parcellation using U-Net with locally constrained optimization. NeuroImage 218: 116819. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kerestes R, Han S, Balachander S, Hernandez-Castillo C, Prince JL, Diedrichsen J, Harding IH (2022): A Standardized Pipeline for Examining Human Cerebellar Grey Matter Morphometry using Structural Magnetic Resonance Imaging. J Vis Exp JoVE. 10.3791/63340 [DOI] [PubMed] [Google Scholar]
- 30.Radua J, Vieta E, Shinohara R, Kochunov P, Quidé Y, Green MJ, et al. (2020): Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA. NeuroImage 218: 116956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Diedrichsen J (2006): A spatially unbiased atlas template of the human cerebellum. NeuroImage 33: 127–138. [DOI] [PubMed] [Google Scholar]
- 32.Buckner RL, Krienen FM, Castellanos A, Diaz JC, Yeo BTT (2011): The organization of the human cerebellum estimated by intrinsic functional connectivity. J Neurophysiol 106: 2322–2345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.van den Heuvel OA, van Wingen G, Soriano-Mas C, Alonso P, Chamberlain SR, Nakamae T, et al. (2016): Brain circuitry of compulsivity. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 26: 810–827. [DOI] [PubMed] [Google Scholar]
- 34.Romer AL, Knodt AR, Houts R, Brigidi BD, Moffitt TE, Caspi A, Hariri AR (2018): Structural alterations within cerebellar circuitry are associated with general liability for common mental disorders. Mol Psychiatry 23: 1084–1090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Zhao G, Zhang H, Ma L, Wang Y, Chen R, Liu N, et al. (2023): Reduced volume of the left cerebellar lobule VIIb and its increased connectivity within the cerebellum predict more general psychopathology one year later via worse cognitive flexibility in children. Dev Cogn Neurosci 63: 101296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Weeland CJ, Kasprzak S, de Joode NT, Abe Y, Alonso P, Ameis SH, et al. (2022): The thalamus and its subnuclei—a gateway to obsessive-compulsive disorder. Transl Psychiatry 12: 70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Hu X, Du M, Chen L, Li L, Zhou M, Zhang L, et al. (2017): Meta-analytic investigations of common and distinct grey matter alterations in youths and adults with obsessive-compulsive disorder. Neurosci Biobehav Rev 78: 91–103. [DOI] [PubMed] [Google Scholar]
- 38.Sörös P, Wölk L, Bantel C, Bräuer A, Klawonn F, Witt K (2021): Replicability, Repeatability, and Long-term Reproducibility of Cerebellar Morphometry. Cerebellum Lond Engl 20: 439–453. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
